# Clustering Approach 4 : METHLYATION_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.112492449054941	Range of duration = 0.03 to 173.79, nDeath = 67, nCensor = 95
2	AGE	ANOVA	0.166504470468066	Range of values = 40 to 85, Mean = 68.1976, StdDev = 8.91205, nMissing = 8
3	GENDER	Fisher's exact test	0.509142986913978	nTypes = 2 (FEMALE/MALE), nPatients = 46/129
4	KARNOFSKY.PERFORMANCE.SCORE	ANOVA	0.238647405449905	Range of values = 0 to 100, Mean = 25.8621, StdDev = 39.1442, nMissing = 146
5	HISTOLOGICAL.TYPE	Chi-square test	0.232382162193351	nTypes = 4 (LUNG BASALOID SQUAMOUS CELL CARCINOMA/LUNG PAPILLARY SQUAMOUS CELL CARCINOMA/LUNG SMALL CELL SQUAMOUS CELL CARCINOMA/LUNG SQUAMOUS CELL CARCINOMA- NOT OTHERWISE SPECIFIED (NOS)), nPatients = 4/1/1/169
6	PATHOLOGY.T	Chi-square test	0.437863501121974	nTypes = 4 (T1/T2/T3/T4), nPatients = 48/99/21/7
7	PATHOLOGY.N	Chi-square test	0.370369349255491	nTypes = 3 (N0/N1/N2), nPatients = 109/50/15, nMissing = 1
8	PATHOLOGICSPREAD(M)	Chi-square test	0.220008989676078	nTypes = 3 (M0/M1/MX), nPatients = 146/1/26, nMissing = 2
9	TUMOR.STAGE	Chi-square test	0.606159106268726	nTypes = 4 (I/II/III/IV), nPatients = 87/53/31/1, nMissing = 3
10	RADIATIONS.RADIATION.REGIMENINDICATION	Fisher's exact test	0.62641317703253	nTypes = 2 (NO/YES), nPatients = 9/166
11	NEOADJUVANT.THERAPY	Fisher's exact test	0.533671834889242	nTypes = 2 (NO/YES), nPatients = 16/159
